Skip to content
OpenCapital
Get started

Prestige Consumer Healthcare PBH G&A

G&A at other companies

Hims & Hers Health logo
Hims & Hers HealthHIMS
$109.67M+126%
FIGS logo
FIGSFIGS
$37.88M+12.0%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S2×-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's G&A?
Prestige Consumer Healthcare (PBH) reported G&A of $30.28M in Q1 2026.
How has Prestige Consumer Healthcare's G&A changed year-over-year?
Prestige Consumer Healthcare's G&A increased by 11.9% year-over-year, from $27.05M to $30.28M.
What is the long-term trend for Prestige Consumer Healthcare's G&A?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's G&A has grown at a 2.0% compound annual growth rate (CAGR), from $107.46M to $116.45M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.